Non-invasive Hemoglobin Screening for Detection of Postpartum Anemia
- PMID: 39206019
- PMCID: PMC11347867
- DOI: 10.1089/whr.2024.0028
Non-invasive Hemoglobin Screening for Detection of Postpartum Anemia
Abstract
Introduction: Postpartum period is a critical period for a woman, where the body of the woman is in healing stage. In this situation, there arises the risk for developing anemia, if proper diet is not maintained. So, it is necessary to routinely determine the hemoglobin levels during this period to avoid chances of developing anemia and assist in early diagnosis.
Methodology: A cross-sectional study was carried out at the maternity ward of Kalinga Institute of Medical Sciences Hospital, Bhubaneswar. The study was conducted for a period of 5-6 months by received approval from the concerned institutional committee. The study involved women participants having age above 18 years and who had recently undergone delivery. Written informed consent was taken from all the participants prior to their enrolment for this study.
Results: A total of 670 women were involved in this study and more than 50% of the women were found to be affected by anemia. A Pearson's correlation of 0.87 was observed with sensitivity of 95.69% and specificity of 67.06% between the hematology analyzer and non-invasive EzeCheck device in determining anemia.
Conclusion: Women often neglect their health situations and always prioritize their family's wellbeing and health over their own. This avoidance results in the development of a chronic disease which in the long run becomes difficult to be cured. So, in such situations, it is necessary to inculcate certain routine tests for the women during their healing period (such as postpartum stage) to keep an eye on their health status. Use of non-invasive devices can help in achieving this in a painless and much effective manner with instant reporting of the results.
Keywords: EzeCheck; hemoglobinometer; non-invasive; postpartum; women health.
© The Author(s) 2024. Published by Mary Ann Liebert, Inc.
Figures



Similar articles
-
Evaluating the Feasibility and Cost-Effectiveness of EzeCheck for Hemoglobin Screening Across India.Cureus. 2024 Nov 3;16(11):e72945. doi: 10.7759/cureus.72945. eCollection 2024 Nov. Cureus. 2024. PMID: 39640123 Free PMC article.
-
Point-of-Care Testing Using Invasive and Non-Invasive Hemoglobinometers: Reliable and Valid Method for Estimation of Hemoglobin among Children 6-59 Months.J Trop Pediatr. 2021 Jan 29;67(1):fmaa111. doi: 10.1093/tropej/fmaa111. J Trop Pediatr. 2021. PMID: 33367788
-
Performance of the non-invasive point-of-care device, EzeCheck, for haemoglobin assessment in adults and children in community and institutional care settings.PLOS Digit Health. 2024 May 8;3(5):e0000500. doi: 10.1371/journal.pdig.0000500. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38717987 Free PMC article.
-
[Post-partum: Guidelines for clinical practice--Short text].J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):1157-66. doi: 10.1016/j.jgyn.2015.09.017. Epub 2015 Oct 31. J Gynecol Obstet Biol Reprod (Paris). 2015. PMID: 26527017 Review. French.
-
Carrier screening for thalassemia and hemoglobinopathies in Canada.J Obstet Gynaecol Can. 2008 Oct;30(10):950-959. doi: 10.1016/S1701-2163(16)32975-9. J Obstet Gynaecol Can. 2008. PMID: 19038079 Review. English, French.
Cited by
-
Evaluating the Feasibility and Cost-Effectiveness of EzeCheck for Hemoglobin Screening Across India.Cureus. 2024 Nov 3;16(11):e72945. doi: 10.7759/cureus.72945. eCollection 2024 Nov. Cureus. 2024. PMID: 39640123 Free PMC article.
References
-
- Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res 2009;130(5):627–633. PMID: 20090119 - PubMed
LinkOut - more resources
Full Text Sources